Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reduced-dose Apixaban”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Study completedNCT03692065
What this trial is testing

API-CAT STUDY for APIxaban Cancer Associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Assistance Publique - Hôpitaux de Paris 1,766
Large-scale testing (Phase 3)Ended earlyNCT03839355
What this trial is testing

Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Mayo Clinic 34
Not applicableLooking for participantsNCT07270263
What this trial is testing

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk 100
Testing effectiveness (Phase 2)UnknownNCT02809469
What this trial is testing

Apixaban Dose Reduction in Patients With Elevated Drug Levels

Who this might be right for
Atrial Fibrillation
Hamilton Health Sciences Corporation 120
Not applicableLooking for participantsNCT07575867
What this trial is testing

CLOT-LESS - CLOsure Tailored: LEss Antithrombotic Strategy After LAAC for Stroke Prevention

Who this might be right for
Atrial FibrillationStroke Prevention in Patients With Atrial FibrillationLeft Atrial Appendage Closure+4 more
National Medical Research Center for Therapy and Preventive Medicine 464
Large-scale testing (Phase 3)Ended earlyNCT02179177
What this trial is testing

Apixaban in Patients With Sickle Cell Disease

Who this might be right for
Vaso-occlusive CrisisReduction in HospitalizationsSickle Cell Disease
Nirmish Shah 16